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3D printing technologies are a promising approach to treat intra-oral bone defects, especially 
those with poor regenerative potential. However, there is a lack of evidence regarding the 
impact of internal design specifications on the bone regenerative potential. Here, we propose 
an in silico approach to optimize the internal design of calcium-phosphate based scaffolds for 
bone regeneration. Based on an in silico model of neotissue formation, a Gyroid 3D-printed 
scaffold was designed and manufactured using UV stereolithography of bioceramic materials. 
An orthogonal lattice structure 3D-printed scaffold and a particulate xenograft were used as 
control groups. The scaffolds were implanted subperiosteally under a shell on rat calvarium for 
4 or 8 weeks and bone neoformation performances were investigated by Nanofocus Computed 
Tomography and decalcified histology. After 8 weeks, the Gyroid group was associated with a 
higher ingrowth potential of the bone and was characterized by signs of osteoinduction (newly 
formed bone islands). The bone to material contact was similar between the Gyroid and the 
particulate groups. The present results reinforce this in silico modelling strategy to design 
calcium phosphate-based 3D scaffolds and the gyroid experimental internal architecture seems 
to be highly promising for intra-oral bone regeneration applications.  
 
1. Introduction 
Despite being very common, intra-oral bone defects are still challenging clinical situations that 
can be lengthy to treat with often unpredictable outcomes owing to the lack of patient-
customized treatment. Although particulate bone substitutes have demonstrated their efficacy 
in self-containing defects, they have shown limitation inherent to their lack in 3-dimensional 
(3D) stability in defects with poor regenerative potential. Alternatively, blocks of different 




tested in animals and humans with most of them displaying the main disadvantages of being 
shaped by hand to fit the patient’s bone defect and containing no or inappropriate 
interconnectivity for neovascularization, reducing their overall bone regenerative 
performances.[1–6] Nowadays, combination of several new technologies such as Computer-
Aided Design - Computer-Aided Manufacturing (CAD-CAM), Cone Beam Computed 
Tomography (CBCT) and high resolution stereolithograhy (SLA),[7–11] enable the fabrication 
of patient-customized 3D scaffolds with tailored dimensions, shape and internal design.[12–15] 
The internal design together with the surface properties are two major factors influencing bone 
regeneration performances of 3D-printed scaffolds.[16–20] Whereas the surface roughness 
depends on biomaterial composition and postproduction processes (sintering t°, coatings,…), 
[21,22] recent 3D printing technologies allow the manufacturing of custom-made scaffolds with 
a multitude of internal design. In silico modelling (the use of computer modeling and 
simulation) is a key approach to avoid the in vivo testing of numerous designs, in accordance 
with the 3 R’s principle, by designing and selecting the most promising patterns according to 
the predictions established by the model. As the efficacy of bone regeneration is dependent of 
a number of parameters, the ideal model should consider as many of them as possible. Besides 
the well-studied factors (biochemical, physical and surface properties), the effect of the 3D 
scaffold internal design is less explored although this parameter has an important impact on the 
tissue formation rate.[23–27] A variety of in silico bone regeneration models has been proposed 
in the literature,[28] with most of them corroborated by comparison with historic or dedicated 
animal experiments. However, most of them focus either on scaffold-free regeneration [29] or a 
specific shape [30–32] rather than using the model to optimize the scaffold structure. In silico 
models focusing on optimizing scaffold internal design to maximize neotissue formation have 
primarily been corroborated by in vitro 3D cell culture experiments.[25,33] 
Previously, we developed an SLA-based approach to fabricate 3D-printed synthetic CaP 




challenged in a subperiosteal cranial rat model using 3D-printed pellets displaying a simple 
macrostructure (rounded unidirectional channels). Although biocompatibility and biological 
performance were demonstrated, the tested scaffolds did not explore different 3D geometries. 
Based on the in silico modelling and using high resolution SLA 3D printers, the present study 
goes one step forward investigating the effect of complex and optimized scaffold on bone 
regeneration.  
The objective of the present study was to reinforce our in silico modelling strategy by evaluating 
the in vivo biological performances of our optimized 3D-printed scaffold (Gyroid) in a small 
animal bone augmentation model compared to a gold standard (granules of Bio-Oss) and a 
classic geometry (Orthogonal). 
 
2. Results 
2.1. In silico modelling 
Neotissue growth was simulated for a variety of lattice-based and Triply Periodic Minimal 
Surface (TPMS) structures. The gyroid-TPMS showed most promising neotissue formation due 
to its favourable local curvature. In a second round of in silico modelling, the gyroid structure 
was further investigated in terms of its pore size and wall thickness, in order to obtain the 
combination leading to optimal neotissue growth. Pore size was varied between 700 µm and 
1.3 mm and wall thickness was varied from 200 µm to 800 µm (Figure 1), which are ranges 
that take into account restrictions of the manufacturing process in terms of smallest feature 
dimensions. Balancing the need for swift neotissue ingrowth (Figure 1B, relevant for short-
term implant stability) with the volume of neotissue formed (Figure 1A, relevant for long-
term implant stability), the combination of 700 µm pore size and 200 µm wall thickness (Figure 





Figure 1. In silico predictions of neotissue formation. Neotissue formation quantified in 
absolute volume (A) and filling percentage (B) for cylindrical test samples (ø 6 mm, height 6 
mm). The different combinations are indicated in the legend by 2 numbers, the first of which 
refers to pore size (7: 700 µm, 10: 1 mm, 13: 1.3 mm) and the second refers to wall thickness 
(2: 200 µm; 5: 500 µm; 8: 800 µm;). (C) Side view and cross-sectional view of neotissue growth 
in gyroid (7-2) scaffold for different levels of filling, starting with initial condition at t=0 (top). 
Scale bars: 6 mm 
2.2. Physico-chemical characterization 
Orthogonal and Gyroid inserts were composed of approximatively 94% of Ca5(PO4)3(OH) 
(hydroxylapatite) and 6% of β-Ca3(PO4)2 (β-TCP) whereas α-Ca3(PO4)2 (α-TCP) was 
undetectable. From a qualitative point of view, SEM analysis revealed similar surface 
roughness of both 3D-printed scaffolds whereas more microporosities were observed for the 





Figure 2. Scanning Electron Microscopy analysis. Surface topographies of the three 
biomaterials are shown at low (500X) and high (1000X) magnifications. 
2.3. In vivo implementation 
2.3.1. Nano-CT analysis 
The percentage of newly formed bone (Bone) within the Total Volume (VOI1) was similar 
between the 3 groups at 4 weeks but was higher in the Gyroid group at 8 weeks compared to 
the Granules and the Orthogonal groups (p < 0.0001) (Figure 3A). Moreover, the percentage 
of Bone increased with time for the Granules (p < 0.05) and the Gyroid (p < 0.0001) groups but 
was stable for the Orthogonal group. Additional output measures were carried out but did not 
change the overall conclusion (Supplementary Materials). At 8 weeks, the highest point of 
Bone was superior for the Gyroid group compared to the Granules and the Orthogonal groups 
(p < 0.0001) (Figure 3B).  Moreover, at 4 and 8 weeks, it was higher for the Orthogonal group 
compared to the Granules group (p < 0.05). This parameter did not evolve with time in the 
Granules and the Orthogonal groups but increased in the Gyroid group (p < 0.0001). 
Interestingly, when looking at these highest points of newly formed bone within the 3D-printed 
scaffolds, we observed that most of them formed self-standing islets of bone, in the Gyroid 





Figure 3. Bone regeneration analysis by Nano-CT. The percentages of newly formed bone 
between the Granules, the Orthogonal and the Gyroid groups were determined within the VOI1 
(A) at 4 and 8 weeks. The bone highest position was calculated at 4 and 8 weeks (B). ns = not 
significant; * = p < 0.05; **** = p < 0.0001. 
2.3.2. Histological descriptive analysis and Bone to Material Contact (BMC) 
At 4 weeks, the scaffolds in all three groups were mainly colonized by soft tissues. Remaining 
blood clots were observed mostly in the centre and the highest areas of the scaffolds. Blood 
vessels were present in each sample but more and larger ones were observed in the 3D-printed 
scaffolds. Few inflammatory cells were noticed in some samples. Early bone colonization, 
characterized by woven bone and starting from the calvarium, was observed in all the 3D-
printed samples but only in some of the Granules group. At 8 weeks, the amount of bone inside 
the scaffolds increased, especially in the 3D-printed scaffolds. Moreover, islets of bone were 
observed at the distal portion of the scaffold in almost all Gyroid group samples. Overall, no 





Figure 4. Representative histological sections from the three experimental groups at 4 and 8 
weeks. At 4 weeks post-implantation, the low magnification pictures (2.5X) allowed to 
visualize a low, localized but similar new bone formation between each of the three 
experimental groups. At 8 weeks, bone formation was still localized in the Granules group 
whereas the 3D-printed scaffolds displayed a widespread bone colonization (low magnification 
pictures). At higher magnification (20X), large blood vessels were observed to be increasingly 





As the Nano-CT analysis revealed weak rates of bone regeneration and highlighted no 
difference between the groups at 4 weeks, the BMC was not determined for this time point. At 
8 weeks, the BMC was superior for the Gyroid group compared to the Orthogonal group (p < 
0.05), with a distribution between approximatively 30 and 50%, and a median of 40%, 
whereas the Orthogonal group displayed a more scattered distribution (10 to 50%) and a 
median inferior to 20%. No difference between the Granules and the Gyroid groups was 
highlighted (Figure 5). 
 
Figure 5. The Bone to Material Contact (BMC) at 8 weeks. The percentages of Bone to Material 
Contact (BMC) were calculated using the 8 weeks histological sections. * = p < 0.05. 
3. Discussion 
This study demonstrates that our 3D-printed HA scaffolds with in silico-optimized internal 
macro-porous architecture (Gyroid group) enhanced bone neoformation in a subperiosteal bone 
augmentation calvarial rat model and, therefore, corroborates the in silico model in its 
qualitative prediction of neotissue growth acceleration between different structures. Although 
the scaffolds from the 3 groups showed similar mineral composition and surface roughness, in 
vivo results highlighted a superior bone regenerative potential in the in silico optimized gyroid 




In silico modelling is widely used for tissue engineering as it offers a more exhaustive approach 
compared to a “trial-and-error” method and reduce the number of experimental tests. 
Optimization of scaffold structures for bone tissue engineering purposes is often corroborated 
by comparison with in vitro tests [25,33] and only a small number of in vivo studies have been 
reported.[35–37] However, in these in vivo studies, optimization was firstly performed on 
mechanical properties rather than the structural elements such as local curvature underlying the 
in silico model used this study.  
HA was chosen to fabricate the 3D-printed scaffolds because among the various CaP ceramics, 
HA is the least soluble, providing a long term 3D stability of the regeneration, and is known to 
be highly biocompatible as its composition is similar to the natural bone matrix.[38]  Thanks to 
its different properties, this CaP ceramic is a widely used synthetic bone substitute for bone 
regeneration procedures.[39] Nano-CT and histological analysis of the in vivo ectopic 
implantation data showed that none of the scaffolds underwent a substantial resorption over the 
experimentation follow-up period as expected from the HA material used in this study. [38] The 
physico-chemical analyses showed that, in all experimental 3D-printed scaffolds, a small 
portion of HA (6%) was transformed in β-TCP which is most likely induced by the sintering 
process. The presence of β-TCP, being more soluble, may actually play a role in the 
regenerative process by releasing Ca+ ions in the environment and contribute to the bone 
forming process.[40] The relatively low sintering temperature used in the present study allowed 
to produce experimental scaffolds with a surface topography rather close to the natural bone 
surface characteristics favourable for cell adhesion, anchoring and proliferation.[34,41,42] 
In vivo results obtained from the Nano-CT analysis highlighted the superior bone regenerative 
potential of the gyroid design with more newly formed bone inside the scaffold, especially in 
the highest parts of the scaffolds. This result emphasized, besides the pore size parameter, the 
critical role of the pore geometry and orientation when designing 3D scaffolds for bone 




highly curved pore corners, tissue growth is favoured within pores displaying numerous corners 
such as hexagons compared to rectangular and triangular pores.[43] Moreover, pore orientation 
may also influence bone regeneration. [46–48] The orientation of the gyroid structure, with waved 
channels running from the parietal bone to the top of the insert, might have allowed for a 
curvotaxis-type of migration of progenitors into the insert.[49]  Finally, the screening of the 3D 
volumes of each sample revealed the presence of independent bone islets in most of the 8 weeks 
Gyroid samples solely. This observation may suggest that this particular design harbour some 
osteoinductive capacity which is in accordance with previous works highlighting the effect of 
pore interconnectivity on bone ingrowth.[48,50,51] Additionally, having even isolated islands of 
bone formation at all levels throughout the implant scaffold, will be beneficial for follow-up 
actions such as oral implant osseointegration.    
The histological analysis revealed no signs of inflammatory reactions neither at 4 weeks nor at 
8 weeks of implantation in any of the three experimental groups, indicating that the 
manufacturing process and post-manufacturing treatment produced biocompatible 3D-printed 
scaffolds as previously described.[34] On the other hand, histological sections showed the 
presence of more and larger blood vessels within the 3D-printed scaffolds compared to the 
Granules group. This observation highlights the importance of internal design to improve bone 
regeneration through an enhanced neovascularization. Indeed, previous reports indicated that 
optimal blood vessels neoformation occurs in macro-pores characterized by a diameter ranging 
from 100 to 800 μm, depending on the experimental conditions. [52–56] 
Finally, the interface between the newly formed bone and the biomaterial surface (BMC) was 
equivalent in the Gyroid and the Granules groups while less contact was found in the 
Orthogonal group. If surface topography was often correlated to the degree of osseointegration 
of regenerative materials, [19,21,57] the present results suggest that additional characteristics such 




Taken together, the present results emphasize the excellent biological performances of the 3D-
printed scaffolds and the better performance of the gyroid design supporting the role that in 
silico modelling can play in designing optimized macro-porous architectures of cell-free 
scaffolds for bone regeneration.  
However, our study encounters some limitations that should be underlined. Simulation results 
have been used in a qualitative way after the curvature-based growth principle was confirmed 
in dedicated in vitro tests but without aiming to provide a detailed quantitative prediction of the 
actual in vivo experiment. Using the proposed in silico model in a quantitative way requires a 
substantial amount of data to fully validate the model. [58–60] The experimental results generated 
in this study can now serve to further validate the in silico model so that it can develop into a 
stand-alone tool for quantitative in vivo neotissue formation prediction. For manufacturing 
reasons, while pore diameter was standardized, pore struts differed between the 3D-printed 
scaffolds, leading to Orthogonal scaffolds with larger struts and thus fewer empty spaces for 
bone neoformation compared to the Gyroid group. This limitation was mitigated by normalizing 
the VOI2 in each group using the VOI2 of the Granules group as reference (Supplementary 
materials). Because of the global dimensions of the scaffolds, it was not possible to implant 
more than one scaffold per animal, resulting in an uncontrolled inter-animal variation. However, 
this weakness was compensated by the high study power (n=10 for every time point in every 
group). Finally, and in order to enhance the standardization of the animal experimentation, 
instead of the usual collagen barrier membrane, a rigid HA-based shell was used to limit the 
ingrowth of soft tissue into the scaffold. However, this is not fully representative of the clinical 
application and similar experiments on bigger animals would be necessary in order to validate 





Within the limits of the present study, we demonstrated that in silico model facilitates the 
internal design optimization of 3D-printed scaffolds for bone regeneration applications. The 
Gyroid design, identified using in silico modelling, displayed better regenerative performance 
compared to the gold standard or the orthogonal printed structures. Further developments in 
larger animal models are however necessary to translate this concept to clinical practice.  
5. Experimental section 
5.1. In silico scaffolds design 
In order to define the optimal scaffold geometry leading to maximal neotissue formation, a 
previously developed in silico model of neotissue growth was used. [61] Full details are provided 
in the supplementary materials. Briefly, neotissue growth in porous scaffolds has been shown 
to be depending on the local mean curvature of the interface between the scaffold and the 
neotissue.[26,62] The in silico model uses the Level Set Method to implement this curvature-
based growth through a simulation of the movement of the interface between the neotissue and 
the void space. The speed of the moving interface is made dependent on the mean local 
curvature, leading to an effective and efficient implementation of the curvature-based 
growth.[61] The model calibration performed in Guyot et al. was for Titanium scaffolds culture 
in a bioreactor setting.[61]  For the purpose of the present study, dedicated calibration 
experiments were performed on prismatic structures, demonstrating a considerably slower 
growth on the CaP scaffolds, nevertheless confirming the curvature-based nature of the growth. 
Neotissue growth was then simulated for a variety of lattice-based structures as well as 
structures from the TPMS family (Figure 6B-C) and compared in a qualitative way. A full 
quantitative prediction is not possible due to the absence of relevant validation experiments, 
which explains why comparisons between geometries are made over non-dimensional time.  
After identification of the gyroid-TMPS as the optimal structure, an additional analysis was 




ingrowth by maximizing speed of growth as well as amount of neotissue formed, while taking 
into account restrictions of the manufacturing process in terms of smallest feature dimensions. 
The gyroid scaffold identified through this process was manufactured along with a lattice-based 
control.  
5.2. Scaffold manufacturing 
Orthogonal and Gyroid inserts as well as shells were implemented in Netfabb by Autodesk 
(Figure 6A-C). They were produced using a SLA machine (Prodways V6000, France) and 
composed of hydroxyapatite as previously described (Figure  6D-F).[34] Briefly, the bioceramic 
was carefully mixed with organic components (polyfunctional acrylic resins and UV-
photoinitiator) in order to obtain a viscous paste material to be processed by SLA (Cerhum and 
Sirris, Belgium). The solid loading was about 50% for both formulations. During the process, 
the suspension was spread on the working area in thin layers of 50 μm. After spreading a layer, 
UV-light was projected by a DLP (Digital Light Processing) on the paste surface. The samples 
were then submitted to a thermal cycle (1125°C, for 5hr) allowing the removal of the resin and 
the densification of the ceramic.[63] After manufacturing, the parts were rinsed and 
ultrasonically cleaned in an ethanol 80% bath for 10 min. As a final step, they underwent an 
autoclave sterilization (134°C for 30 min) before in vivo implantation. 
5.3. Physico-chemical characterization 
Gyroids and orthogonal parts were analysed using a diffractometer (Rigaku Miniflex 600) in 
order to identify and quantify their mineralogical phases. Moreover, a qualitative analysis of 
their surface microtopography was carried out with a scanning electron microscope (SEM). 
Scaffolds were mounted on SEM stubs and coated with platinum using a Q 150T S sputter 
coater (Quorum Technologies, West Sussex, UK). The sample surface analysis was performed 




5.4. In vivo implantation 
5.4.1. Animals and study design 
Subperiosteal implantation of the scaffolds was performed in a calvaria rat model in order to 
determine the impact of the scaffold internal design on the bone augmentation performances in 
vivo. All experimental procedures used in this investigation were reviewed and approved by 
the Institutional Animal Care and Use Ethics Committee of the University of Liège, Belgium 
(ethical number 1527). Animal Research Reporting of In Vivo Experiments guidelines were 
carefully followed as well as national and European legislation.[64] The male Wistar rats were 
acquired from the University of Liège and randomly allocated into 6 groups (three experimental 
scaffolds: Granules, Orthogonal and Gyroid; two time points: 4 and 8 weeks). 
5.4.2. Global scaffold design 
Scaffolds were produced in two parts, an insert (3.4 mm in length, 5,1 mm in width and 4 mm 
in height) and a shell (6.5 mm in length, 5 mm in width and 5 mm in height, 0,7 mm wall 
thickness), with their respective dimensions allowing a perfect assembly of the insert into the 
shell. To play the role of a barrier and allow bone ingrowth exclusively from the calvarium, the 
shell was not perforated (Figure 6A-F). In addition, both inserts and shells displayed a slight 
curvature on their lower side to best fit the animal’s skull. Shell design was identical for the 3 
groups both types of scaffolds.  The insert designs corresponded to a lattice structure with 
square struts (Orthogonal group, pores diameter of 700 µm) or a gyroid structure (Gyroid group, 
pores diameter of 700 µm) while in the granule group the particles diameter ranged from 0.25 
to 1 mm (Bio-Oss, Geistlich, Wolhusen, Switzerland).  
5.4.3. Surgical procedure 
Animals were anaesthetized with a combination of Ketamine (8 mg/kg) and Xylasine (5 mg/kg) 
administered intraperitoneally, the surgical site was shaved and few blood drops were collected 




Septodont, France), an antero-posterior incision was performed on the calvarium. A full 
thickness skin flap was raised in order to exhibit the entire parietal bone (Figure 6G). Before 
implantation, the Bio-Oss particles were mixed with the collected blood while the inserts were 
filled in with it. The experimental specimens were then placed into a shell and a single scaffold 
was implanted over the sagittal calvarial suture in each animal according to the randomization 
(Figure 6H). The surgical site was sutured with polypropylene 5/0 (Permashap, Hu Freidy, 
USA) (Figure 6I). Antibiotics (Baytril, 5 mg/kg), painkillers (Temgésic, 0.05 mg/kg) and anti-
inflammatory (Rimadyl, 5 mg/kg) drugs were administrated subcutaneously.  After 4 and 8 
weeks, rats were euthanized by an overdose of pentobarbital (Euthasol). The samples were 
harvested and fixed for 24 hours in 4% formaldehyde and then stored in PBS at 4°C until Nano-
CT acquisition. 
 
Figure 6. 3D designs based on the computational model, 3D-printed parts and surgical 
procedure. (A – C) Gyroid structures were suggested by the in silico model and compared to a 
lattice-based orthogonal structure and the clinical gold standard. (D – F) Shells and inserts were 
printed by stereolithography. (G – I) The surgical procedure is depicted. Blue arrows: detached 





5.4.4 Nanofocus Computed Tomography (Nano-CT)  
Nano-CT scans of the samples were acquired using the GE Phoenix Nanotom (Hawker 
Richardson, New Zealand). Scanning was carried out at 75 kV, 140 µA and with a 0.5 mm 
Aluminium filter. A total of 1800 images were taken over a 360° scan using the fast scan mode 
with a resolution of 5.5 µm per voxel. Scans 3D reconstruction was performed using Phoenix 
datos|x CT and then reoriented adequately with DataViewer (Bruker micro-CT, Kontich). 
Using the same software, the experimental inserts were selected excluding the shell. The 
selected volume (Total Volume, VOI1) was then quantitatively analysed with CTAn (Bruker 
micro-CT, Kontich). The quantity of newly formed bone was determined using a segmentation 
based on the grey levels. The percentage of bone was then calculated within the VOI1 as 
follows: 
Bone within VOI1 (%) =
Volume of Bone
VOI1
 x 100 
Additional methodologies for bone volume quantification are presented in the supplementary 
materials. 
As not only the quantity of bone but also the ingrowth into the scaffold is of importance, the 
distance between the parietal bone and the highest point of newly formed bone within the 3D 
scaffolds was measured in all samples as follows:  
% =
Highest point of Bone
Total height of the scaffold
 x 100 
5.4.5. Qualitative histological analysis and Bone to Material Contact calculation 
Following a decalcification procedure of two days using a mixture of hydrochloric acids (DC2, 
VWR,USA), the samples were embedded in paraffin. Five µm-thick longitudinal sections were 
obtained from three different levels of the samples and stained with hematoxylin and eosin. The 
histological sections were then scanned (NDP NanoZoomer Digital Pathology, Hamamatsu, 




Additionally, for the 8 weeks samples, the percentage of Bone to Material Contact (BMC) was 
calculated in areas where newly formed bone was present as follows: 
BMC (%) =
Perimeter of Biomaterial in contact with Bone
Total Perimeter of Biomaterial
 x 100 
5.5. Statistical analysis 
5.5.1. Sample size calculation 
The required sample size was determined using the software Gpower. [65] The effect size was 
set at 0.55 and the power at 0.95. Thus, the calculated total sample size was 55 but it was 
rounded up to 60 according to the study design (6 groups with 10 animals per group). 
5.5.2. Statistical tests 
Statistical tests were carried out using GraphPad 8.3.0. Normality tests (D’Agostino & Pearson) 
were performed following outliers’ identification (ROUT test with Q = 1%) and withdrawal. 
The percentage of Bone to Material Contact (BMC) was analysed using a One-Way ANOVA 
whereas a Mixed-effect model (REML) was used to analyse the % of Bone within the VOI1 
and the highest point of newly formed bone. Tukey’s and Sidak’s corrections were applied for 
multiple comparisons. The data were presented as violin plots with quartiles and medians. 
 
Supporting Information  
Supporting Information is available from the Wiley Online Library or from the author. 
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applications. This study validates this approach and shows that the Gyroid design is associated 
to a strongly enhanced bone regenerative capacity when implanted in a small animal model. 
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